At PROCEPT BioRobotics, we are establishing a new standard of care in the surgical treatment of Benign Prostatic Hyperplasia (BPH). We are very proud that our products improve the lives of patients and their families. We also know that our ability to make a positive contribution to the world is broader than the products we make. That is why we consider environmental, social and governance (ESG) factors at PROCEPT BioRobotics and seek to create sustainable value and advance the interests of all our stakeholders globally – patients, providers, employees, and stockholders. As PROCEPT BioRobotics continues to grow, we are committed to sharing updates related to our ESG programs, priorities, goals, and performance.